Perez Stachowski, J.; Rial Crestelo, D.; Moreno Zamora, A.; Cabello, N.; Ryan, P.; Espinosa Aguilera, N.; Bisbal, O.; Vivancos Gallego, M.J.; Nuñez, M.J.; Troya, J.;
et al. Use of Tenofovir Alafenamide/Emtricitabine/Elvitegravir-Cobicistat in HIV-Naive Patients with Advanced Disease: GENIS Study. J. Clin. Med. 2022, 11, 4994.
https://doi.org/10.3390/jcm11174994
AMA Style
Perez Stachowski J, Rial Crestelo D, Moreno Zamora A, Cabello N, Ryan P, Espinosa Aguilera N, Bisbal O, Vivancos Gallego MJ, Nuñez MJ, Troya J,
et al. Use of Tenofovir Alafenamide/Emtricitabine/Elvitegravir-Cobicistat in HIV-Naive Patients with Advanced Disease: GENIS Study. Journal of Clinical Medicine. 2022; 11(17):4994.
https://doi.org/10.3390/jcm11174994
Chicago/Turabian Style
Perez Stachowski, Javier, David Rial Crestelo, Ana Moreno Zamora, Noemi Cabello, Pablo Ryan, Nuria Espinosa Aguilera, Otilia Bisbal, Maria Jesus Vivancos Gallego, Maria Jose Nuñez, Jesus Troya,
and et al. 2022. "Use of Tenofovir Alafenamide/Emtricitabine/Elvitegravir-Cobicistat in HIV-Naive Patients with Advanced Disease: GENIS Study" Journal of Clinical Medicine 11, no. 17: 4994.
https://doi.org/10.3390/jcm11174994
APA Style
Perez Stachowski, J., Rial Crestelo, D., Moreno Zamora, A., Cabello, N., Ryan, P., Espinosa Aguilera, N., Bisbal, O., Vivancos Gallego, M. J., Nuñez, M. J., Troya, J., Dominguez, M., & Sierra, J. O.
(2022). Use of Tenofovir Alafenamide/Emtricitabine/Elvitegravir-Cobicistat in HIV-Naive Patients with Advanced Disease: GENIS Study. Journal of Clinical Medicine, 11(17), 4994.
https://doi.org/10.3390/jcm11174994
